ClinicalTrials.gov
public full text
Public Domain
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
This randomized phase I trial studies the side effects and best dose of defined green tea catechin extract in treating women with hormone receptor-negative stage I-III breast cancer. Green tea extract contains ingredients that may prevent or slow the growth of breast cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis#854251
- Green Tea and Reduction of Breast Cancer Risk#1151530
- Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study#886370
- Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans#1127970
- Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer#830162
Record · ID 1073604
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive